The 2nd Xiangya Hospital, Central South University
Changsha, Hunan, 410011, China
NCT Number: NCT04960033
We evaluated fracture risk assessment tools (FRAXs) from different regions in Chinese postmenopausal women.
Looking for future studies?
Notify Me50 year and older
Female
Observational
Changsha, Hunan, 410011, China
This cross-sectional study recruited 264 postmenopausal women aged ≥50 years in September 2017. Basic information, general condition, history of illness, family history, and clinical risk factors were evaluated via a questionnaire. All subjects underwent a bone mineral density examination of the femur and lumbar spine and thoracolumbar spinal X-ray. The 10-year major osteoporotic fracture (MOF) and hip fracture (HF) risks were calculated using FRAXs from mainland China, Hong Kong, Taiwan, and Asia-America. All data were analyzed using SPSS 17.0. Sensitivity, specificity, and likelihood ratio were used to compare the effectiveness of each FRAX.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America). Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was ≥20% or the 10-year probability of HF was ≥3%.
Time frame: 2017years
The 10-year MOF probability and the 10-year HF probability were calculated using the FRAXs of different regions (mainland China, Hong Kong, Taiwan, and Asia-America). Subjects were deemed as high-risk for osteoporotic fracture if the 10-year probability of MOF was ≥20% or the 10-year probability of HF was ≥3%.
Central South University
Other
Central South University
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05366621
Adherence, Medication, Behavior
Tainan, Taiwan
View Trial DetailsNCT03710889
Bone Diseases, Bone Diseases, Metabolic
Golden, Colorado, United States
View Trial DetailsNCT03798444
Back Injuries, Bone Diseases
Changsha, Hunan, China
View Trial DetailsNCT02483286
Atrophy, Behavior
Taipei, Taiwan
View Trial Details